Tongfang Kontafarma Holdings Overview

  • Founded
  • 1993

Founded
  • Status
  • Public

  • Employees
  • 1,365

Employees
  • Stock Symbol
  • 01312

Stock Symbol
  • Investments
  • 2

Tongfang Kontafarma Holdings General Information

Description

Kontafarma China Holdings Ltd is principally engaged in the manufacture and sale of prescription drugs including chemical drugs and traditional Chinese medicine in the PRC, and the operation of fitness centers, provision of fitness and health consulting services, and the operation of franchises.

Contact Information

Formerly Known As
Allied Cement Holdings
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Holding Companies
Stock Exchange
HKG
Primary Office
  • 9th Floor, Allied Kajima Building
  • 138 Gloucester Road, Wanchai
  • Hong Kong
  • Hong Kong
+852 2111 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tongfang Kontafarma Holdings Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$39.9M 5.59B 2.34M

Tongfang Kontafarma Holdings Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 122,056 129,848 219,489 275,994
Revenue 131,603 123,646 130,094 117,558
EBITDA 25,190 22,595 20,065 30,176
Net Income 3,751 (1,936) (34,442) 4,607
Total Assets 313,407 328,130 327,937 513,593
Total Debt 74,683 93,479 100,951 115,301
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tongfang Kontafarma Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tongfang Kontafarma Holdings‘s full profile, request access.

Request a free trial

Tongfang Kontafarma Holdings Executive Team (5)

Name Title Board Seat Contact Info
Chaowen Jiang Chief Executive Officer, Executive Director & Vice President
Hongjie Chai Executive Director
You’re viewing 2 of 5 executive team members. Get the full list »

Tongfang Kontafarma Holdings Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tongfang Kontafarma Holdings Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tongfang Kontafarma Holdings‘s full profile, request access.

Request a free trial

Tongfang Kontafarma Holdings Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 03-May-2018 000000000 000.00 Pharmaceuticals
Tongfang Pharmaceutical Group 28-Jan-2016 Secondary Transaction - Private 000.00 Pharmaceuticals
To view Tongfang Kontafarma Holdings’s complete investments history, request access »

Tongfang Kontafarma Holdings Subsidiaries (1)

Company Name Industry Location Founded
00000000 000000000 Pharmaceuticals Beijing, China 0000
To view Tongfang Kontafarma Holdings’s complete subsidiaries history, request access »

Tongfang Kontafarma Holdings ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Construction Materials

Industry

Rank

Percentile

Construction Materials

Subindustry

Rank

Percentile

To view Tongfang Kontafarma Holdings’s complete esg history, request access »